Author: admin

What Makes Firm abs Different? A Decade of Proof

There’s a hidden gem beloved by countless women worldwide. Often hailed as their “go-to” for workouts, this activewear brand has garnered a dedicated following. You might be familiar with the name Firm abs. So, what sets this brand apart?

Steering clear of the traditional paths of major brands like Lululemon focusing on yoga pants, Firm abs innovated by starting with cargo leggings, ideal for strength training.

 

Firm abs: Original Cargo Leggings Designer

Nowadays, it’s common to see leggings with pockets, but did you know that Firm abs was the original creator of this design? Firm abs blends comfort, style, and functionality to create activewear perfect for the gym, boxing, rock climbing, and beyond. Empowering women to conquer any challenge, the brand embodies the Spirit of Independence, transforming apparel into armor for the self-determined.

Firm abs’ iconic Original Cargo Design is a testament to this spirit, offering both practicality and style. Featuring a multi-pocket design, these innovative leggings have redefined fitness fashion. Crafted for durability and adventure, the Cargo line empowers women with every pocket and stitch.

Firm abs: Celebrating Independence and Empowerment

Driven by its unique brand spirit, “Independent Spirit,” Firm abs is dedicated to empowering women through a perfect blend of style, function, and freedom. The brand’s “Free to Lead” mantra inspires confidence and resilience, equipping women to conquer their goals. Each design celebrates individuality, reflecting a woman’s unique power and strength.

Firm abs: Building a Reputation on Quality and Service

Thanks to its focus on quality, Firm abs has garnered a loyal following. This commitment to quality is reflected in customer testimonials:

“Firm abs is my go-to for activewear. I also love this brand for rock climbing and have received many compliments on the sportswear.”

This sentiment is echoed by many Firm abs customers, solidifying the brand’s reputation for top-notch quality and outstanding customer service.

Firm abs: A Decade of Empowering and A Look to the Future

Founded in 2014, Firm abs is going to celebrate its 10th anniversary with exclusive deals and discounts from September 9th-18th. To mark this milestone, the brand is launching three collections.

Ten years marks a new beginning for a brand. Firm abs is excited to deepen its roots in this industry and bring the customers even more innovative activewear.

Media Contact
Company Name: Firm abs
Contact Person: Flora
Email: Send Email
Country: United States
Website: https://www.firmabs.com/

User Review: VUUDL’s Automation Services Are a Must-Have for Serious Ecommerce Entrepreneurs

As an ecommerce business owner, finding the right partners to help grow your brand is crucial. After struggling to manage everything on my own, I decided to give VUUDL’s automation services a try—and I couldn’t be more impressed.

From the start, VUUDL’s team took the time to understand my business, crafting a personalized strategy that catered to my specific needs. Their expertise in Amazon automation has been a game-changer for me. Before working with them, my Amazon store was doing okay, but it was clear I wasn’t tapping into its full potential. After partnering with VUUDL, I watched my sales double within just a few months. They handled everything, from product research to listing optimization and order fulfillment, allowing me to focus on other aspects of my business.

Expanding to TikTok was something I knew I had to do, but I wasn’t sure how to go about it. VUUDL stepped in and set up my TikTok Shop, automating the process and making it as seamless as possible. While it’s still early days, I’m already seeing positive results, and I’m confident that VUUDL’s expertise will help me unlock even more potential on this platform.

One of the standout aspects of working with VUUDL has been their communication and support. It’s easy to feel overwhelmed and alone in the ecommerce world, but VUUDL’s team was always there to guide me. They were responsive, proactive, and always ready to answer my questions or provide updates on my progress. Knowing that I had a dedicated team behind me gave me peace of mind.

But what really sets VUUDL apart is their personalized approach. They don’t offer a cookie-cutter solution. Instead, they took the time to understand my unique challenges and goals, tailoring their services to fit my needs perfectly. It’s not just about automation—it’s about having a true partner who’s invested in your success.

Overall, VUUDL’s automation services have been a transformative experience for my business. If you’re serious about scaling your ecommerce brand, I highly recommend giving them a try. They’ve helped me achieve results I never thought possible, and I’m excited to see where they’ll take my business next.

Rating: 10/10

Media Contact
Company Name: VUUDL Media Group
Contact Person: Media Relations
Email: Send Email
Country: United States
Website: https://www.vuudl.com/

TravelThru Sets New Standards in Transportation with Unparalleled Service

Singapore – This summer, TravelThru, a premier transportation company based in Singapore, is setting new benchmarks in the travel industry with its unwavering commitment to safety and convenience. More than just a transport provider, TravelThru has established itself as a trusted travel companion for customers across the globe.

In a time when the demand for passenger transport is surging, TravelThru has emerged as a frontrunner in the industry, offering high-quality, safe, and seamless transportation solutions. Dedicated to enhancing travel experiences, the company meets and exceeds international standards in catering to diverse customer needs.

TravelThru: Your Trusted Travel Partner

Catering to both individual and corporate clients, TravelThru offers a range of professional transportation services designed to simplify journeys and provide peace of mind. With a focus on delivering premium service, TravelThru tailors its offerings to meet the varied needs of its clientele.

Key Services Offered by TravelThru:

  • Airport Transfers: TravelThru’s airport transfer service, supported by experienced and professional drivers, ensures that customers enjoy a smooth, stress-free journey from the airport to their destination.
  • A to B Rides: With an easy booking process and a team of skilled drivers, TravelThru provides efficient transportation from one point to another, ensuring maximum comfort throughout the ride.
  • Private Chauffeur Service: For those seeking luxury and convenience, TravelThru’s private chauffeur service offers an elevated travel experience, combining comfort and prestige.
  • Group Bookings: Ideal for group travel, whether for friends, family, or corporate events, TravelThru’s group booking service offers convenience and flexibility, ensuring that every journey is tailored to the group’s needs.


Why TravelThru is a Customer Favorite:

Operating under the guiding principles of “Safety – Comfort – Excellence,” TravelThru consistently enhances service quality, earning the trust and satisfaction of its customers through several key factors:

  • Modern, High-Quality Fleet: TravelThru maintains a fleet of well-maintained, regularly upgraded vehicles that guarantee both safety and comfort. These premium vehicles come equipped with the latest amenities, offering passengers a superior travel experience.
  • Global Service Network: Beyond Singapore and Southeast Asia, TravelThru has expanded its services internationally, ensuring that customers receive top-notch care no matter where their journey takes them.
  • Competitive Pricing: TravelThru is committed to offering competitive pricing, making its high-quality services accessible to a wide range of budgets.
  • User-Friendly Technology: With a mobile app and website designed for ease of use, TravelThru makes it simple for customers to book, manage, and track their journeys, providing a hassle-free experience.
  • 24/7 Customer Support: TravelThru’s dedicated customer service team is available around the clock, ready to assist with any inquiries and ensure that services are delivered to the highest standard.


Contact TravelThru to Elevate Your Travel Experience

TRAVELTHRU

Address: 8 Boon Lay Way, #11-08, 8@Tradehub 21, Singapore

Hotline: +1 (415) 855-3868

Website: https://travelthru.com

With its superior service quality, reasonable pricing, flexibility, and professional support, TravelThru is committed to delivering unparalleled satisfaction to all its customers. Make TravelThru your go-to partner for a premium transportation experience, wherever your journey may take you.

Media Contact
Company Name: TravelThru Pte. Ltd.
Contact Person: Tan Mai
Email: Send Email
City: Singapore
Country: Singapore
Website: https://travelthru.com/

Outdoor Exposure Tree Service Earns A+ Rating with BBB for Outstanding Customer Service

Outdoor Exposure Tree Service Earns A+ Rating with BBB for Outstanding Customer Service
The North Carolina-based company offers necessary tree services across the state and has recently earned an A+ rating from BBB, Better Business Bureau, reflecting on their trustworthiness and reliability.

BBB is a reliable source for consumers in the United States and Canada to research about businesses. The company has been helping people find local companies since 1912. They use different grades, “A to F”, that reflect on performance, reputation, and customer satisfaction. Multiple factors are considered to mark a company out of 100. An A+ is given when a company scores 97 or higher. Considering that, it can be said that the Outdoor Exposure Tree Service has performed great in serving the people of North Carolina. 

North Carolina, a state with more than 14 billion trees in timberland, boasts a community that loves trees. People of the state are serious about taking care of their trees. Outdoor Exposure Tree Service has been helping them for several years now. The company provides various services across the state, including  Thomasville, High Point, Greensboro, and other cities. They have trained and certified arborists and technicians. The inclusion of modern technology in their service promotes better and safer service. One of the staff members shares, “When at service, our experts inspect the situation first to design a personalized solution for each client. We believe that no two properties or trees are alike.”

More information is available at https://outdoorexposuretreeservice.com/

The company has built a solid reputation for itself with its top-class services in handling any tree problems. The BBB rating is evidence of their transparency, honesty, and professionalism in handling customer complaints. This also solidifies that the company is compliant with legal and industry standards, making them a reliable option for tree servicing in the locality. 

They offer different services and are always available to serve. Here is a list of their services:

Tree Removal: Their trained arborists can remove trees of any size. From Red Maple or Florida Maple to Betula nigra and  American Hornbeam, they can efficiently and safely remove any trees. 

Tree Trimming: With strategic pruning and trimming, they remove diseased and overly large branches. This improves growth, aesthetics, and increases safety during storms and strong winds. 

Stump Removal: Stumps in the backyard often pose risks of accidents, especially for children. The expert staff of the company can remove the stumps from the ground, regardless of the size, with modern equipment. This makes the backyard safe to walk around. 

Land Cleaning: Outdoor Exposure Tree Service also offers land cleaning services that may be needed for construction or to improve the appearance. Their service includes removing bushes and leveling up the ground. Being a responsible company, they provide this service with proper caution, ensuring no harm is done to nature. 

Emergency Tree Service: Trees can get fallen, uprooted, or lean dangerously to one side. This poses threats for property damage as well as life risks for the residents. Outdoor Exposure Tree Service is always ready to help in such situations. Their emergency service is available 24/7, and with easy communication, they arrive ready at the spot quickly and help restore safety. 

The tree service company has a dedicated team that is friendly and committed to its work. Their A+ rating from the BBB is well-deserved. This recognition and reputation will motivate them to heighten their standard of service and continue exceeding customer expectations.

About Outdoor Exposure Tree Service

They have built a reputation for prompt service and pristine results. Their expert arborists and technicians operate critical tasks smoothly without causing any damage to the property or to nature.

Connact with them at: https://www.facebook.com/outdoorexposuretreeservices/?_rdc=2&_rdr

Media Contact
Company Name: Outdoor Exposure Tree Service
Contact Person: Scott
Email: Send Email
Phone: 336-920-7578
Address:172 Hasty School Rd
City: Thomasville
State: NC 27360
Country: United States
Website: https://outdoorexposuretreeservice.com/

SkillFusion, Edtunity, and Virginia Clean Cities Partner on EV Charger Technician Certifications for Veterans in Virginia

The education and certification program, funded through an Electrify America investment to Edtunity, will cover the cost for training veterans on the skills needed to support the growing EV charging network and unlock new career opportunities.

Detroit, MI – SkillFusion, an industry-first software platform for electric vehicle service equipment (EVSE) operations and maintenance (O&M) providers, has announced a partnership with the Edtunity Institute and Virginia Clean Cities to provide free EV charger technician credentialing for veterans, members of the National Guard, or military reservists. Individuals will have access to SkillFusion’s first-of-its-kind EVSE skill enhancement and certification. The program provides non-electricians with the needed skills and certifications to carry out specific technical work on EV chargers, such as servicing communication and networking systems. 

“Nearly a million service members transition out of the U.S. Armed Forces every four years. While these men and women represent our country’s most valuable and highly trained talent, many struggle to find rewarding careers matching their acquired skills, interests, and desired location,” said Elaina Farnsworth, co-founder and CEO of SkillFusion. “Through our program, veterans will be specially trained for exciting opportunities within the EV sector and set on a path for success.” 

Through an investment by Electrify America announced last fall, Edtunity working with partners will use the investment toward tuition to train veterans. To date, 50 veterans have started training to receive their certification. 

“Electrify America is committed to supporting the workforce of the future through our investments in STEM education and training,” said Robert Barrosa, president and CEO of Electrify America. “Our investment in organizations like Edtunity will help veterans receive technical training and job placement while helping ensure the success of the industry.” 

SkillFusion’s groundbreaking credentialing program provides charger-agnostic skill enhancement and certification covering the full spectrum of skills needed to support EV charger operations. SkillFusion’s skill enhancement programs will help people develop a valuable skill set, earn an industry-certified credential, and enhance their professional credibility and work readiness. Once a veteran receives their credential, Edtunity Institute will work towards placing students with service jobs in their area.

“As a non-profit organization, we are extremely grateful for grant opportunities such as this that allow Edtunity to expand our reach and contribute to the community in a positive and impactful way,” said Edtunity Founder and CEO Jimmie L. White. “Our partnership with SkillFusion allows us to offer a fully comprehensive curriculum to veterans and individuals who want to transition into the rapidly growing EV market.” 

This 20-hour credentialing program signifies that an individual possesses the necessary foundational understanding of electric vehicle infrastructure and maintenance requirements including the ecosystem, communication technologies, software, applications, security, safety, and more — providing an opportunity for employment in diagnostics, non-electrical technical support, and as a critical liaison to electricians, electrical contractors, and EVSE installation program managers. 

About SkillFusion 

SkillFusion is a first-of-its-kind approach to provide electric vehicle operations and maintenance (O&M) service providers with access to a nationwide credentialed talent pool for electric vehicle service equipment (EVSE) O&M obligations. Through the company’s cross-sector training platform, SkillFusion is developing the largest talent pipeline of certified electrician and non-electrician workers available to EVSE O&M service providers with the mission to minimize charging infrastructure downtime and increase the reliability of the charging network. The platform will increase availability of certified EVSE workers ensuring that service providers have immediate accessibility to the right trained service technician for every job, every single time.

To learn more about SkillFusion, visit www.SkillFusion.com

About Edtunity 

Edtunity Institute, formerly Capital Commitment of Virginia, is a non-profit organization established in 2001 in response to the needs of unemployed individuals in the Hampton Roads Area. Its founders saw a rising future in the telecommunications industry. As a result, the founders established a comprehensive job training and education program to support neighborhood-based partnerships to train and employ low-income minority group members in high-skill, high-wage telecommunications trades. The purpose of Edtunity’s job training program is to increase the overall participation of community members. Edtunity is focused on building bridges between all segments of the community and the private sector. We work hard to develop partnerships to present opportunities to the unemployed, at-risk youths, veterans, welfare recipients, and single parents through job training and education.

Media Contact
Company Name: SkillFusion
Contact Person: Caleb Harper
Email: Send Email
Country: United States
Website: www.skillfusion.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: SkillFusion, Edtunity, and Virginia Clean Cities Partner on EV Charger Technician Certifications for Veterans in Virginia

Mobile Kitchin Revolutionizes the Restaurant Industry with Innovative Rental Platform

Platform creates new revenue streams for restaurant owners by maximizing space utilization.

Mobile Kitchin has launched an innovative service that is set to transform the restaurant industry. This pioneering platform allows restaurant owners, food truck operators, café managers, and food cart vendors to rent out their spaces during idle times, creating a new revenue stream that can help sustain their businesses and boost profitability.

The concept behind Mobile Kitchin is both straightforward and ingenious. Typically, when a restaurant closes for the day or goes on vacation, its space often sits unused, generating no income. Mobile Kitchin changes this dynamic by enabling restaurant owners to list their kitchens, dining areas, or entire establishments for rent. This allows chefs, caterers, and other culinary professionals to host pop-up events, test new concepts, or extend their culinary reach, all within an established venue.

“We’re thrilled to introduce Mobile Kitchin, a service designed to help restaurant owners make the most of their downtime while giving chefs the opportunity to showcase their talents in prime locations,” said Jamec Blue, VP of Mobile Kitchin. “Our platform is crafted to be beneficial for everyone involved, from the restaurant owners to the chefs and the broader food community.”

One of the key benefits of Mobile Kitchin is its user-friendly platform. Restaurant owners can easily list their available times and spaces, while chefs can browse these listings, check availability, and book the space that suits their needs. This seamless process is further enhanced by the Mobile Kitchin app, which is available for free download through the website www.mobilekitchin.com. The app ensures that both restaurant owners and chefs can manage their listings and bookings conveniently, even while on the go.

“Mobile Kitchin is more than just a rental service; it’s a community that brings together culinary professionals and food enthusiasts,” added Blue. “We’re excited to see the creative ways chefs and restaurant owners will use our platform to grow their businesses and delight their customers.”

For more information about Mobile Kitchin and to join this culinary revolution, visit www.mobilekitchin.com.

About Mobile Kitchin

Mobile Kitchin is an innovative platform that connects restaurant owners with chefs looking to host pop-up events. By renting out unused kitchen and dining spaces, Mobile Kitchin helps businesses create new revenue streams, increase employee pay, and engage with their community in exciting new ways.

For more information, please visit www.mobilekitchin.com

Media Contact
Company Name: Mobile Kitchin
Contact Person: Jamec Blue
Email: Send Email
Phone: 307-429-2032
Country: United States
Website: https://www.mobilekitchin.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Mobile Kitchin Revolutionizes the Restaurant Industry with Innovative Rental Platform

SouthStar Capital Provides $740,000 Purchase Order/Factoring Facility for Government Contracting Opportunity

Charleston, SC – August 15th, 2024 – SouthStar Capital is proud to announce the successful provision of a $750,000 Purchase Order/Factoring Facility to a small business specializing in government contracting. This financing solution played a pivotal role in enabling the company to secure a substantial contract with a prominent school system in the western United States.

The company was presented with a significant opportunity to supply products to a leading school system. However, to fulfill this contract, they needed to make upfront payments to their supplier, ensuring that the products could be shipped promptly. SouthStar Capital stepped in to provide a $750,000 Purchase Order/Factoring Facility, empowering the company to settle its obligations with the supplier and facilitating the timely shipment of the required products.

With immediate access to the necessary funds, the company successfully executed the contract, delivering products on schedule. This accomplishment not only secured a prestigious contract but also reinforced the company’s reputation for reliability and efficiency in the competitive government contracting sector. SouthStar Capital remains dedicated to offering flexible financing solutions that help businesses seize new opportunities and overcome financial challenges.

About SouthStar

SouthStar Capital is a nationwide commercial finance company with a 16-year track record of excellence, innovation, and customer satisfaction. We specialize in providing comprehensive, customized working capital solutions, including Accounts Receivable Financing, Asset-Based Lending, Purchase Order Financing, Equipment Leasing, Government Contracting, Invoice Factoring, and Payroll Funding. Our non-traditional approach to funding allows us to cater to a wide range of businesses, from startups seeking growth financing to established companies needing enhanced cash flow.

For more Information Visit https://www.southstarcapital.com/government-contract/southstar-capital-750k-financing-facility-secures-government-contract

Media Contact
Company Name: SouthStar Capital
Contact Person: Becca Ripley
Email: Send Email
Phone: (843) 800-8339
Address:840 Lowcountry Blvd
City: Mount Pleasant
State: SC 29464
Country: United States
Website: www.southstarcapital.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: SouthStar Capital Provides $740,000 Purchase Order/Factoring Facility for Government Contracting Opportunity

Metallic Stearates Market Application, Growth, Opportunities, Leading Companies, Share, Global Size, Key Segments Analysis, Regional Insights, and Forecast to 2028

“Browse 187 market data Tables and 37 Figures spread through 190 Pages and in-depth TOC on “Metallic Stearates Market””
The Metallic Stearates Market is growing with rising demand in plastics, rubber, and cosmetics. Top regional growth is observed in Asia-Pacific and North America, fueled by expanding industrial applications and increased production capacities.

The global metallic stearate market is approximated to be USD 3.7 billion in 2023, and it is projected to reach USD 4.9 billion by 2028 at a CAGR of 5.4%. Metallic stearates are metal salts of fatty acids, primarily stearic acid, that are used as additives in various industries such as plastics, rubber, construction, and pharmaceuticals. The primary function of metallic stearates is to act as lubricants, release agents, and stabilizers, improving the properties of the final product.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=157185802 

The market of metallic stearates has been segmented based on the type, i.e. zinc stearates, calcium stearates, magnesium stearates, aluminum stearates, and others. Zinc stearate has the largest market share in metallic stearates market in 2022. Zinc stearate is a white, powdery substance that is widely used as a release agent in the production of rubber and polyurethane foam. It is also used as a lubricant and stabilizer in plastics. In rubber manufacturing, it is added to the compound to prevent it from sticking to the molds during the vulcanization process. In polyurethane foam production, it acts as a blowing agent and releases the foam from the molds. Zinc stearate is also added to plastics to improve their flow properties and to prevent them from sticking to processing equipment. Furthermore, calcium stearate is a white, waxy substance that is commonly used as a lubricant and release agent in the production of plastics, rubber, and paper. In plastic manufacturing, it is added to PVC to improve its processing properties and to prevent it from sticking to processing equipment. In rubber production, it is used as a mold release agent and to prevent the rubber from sticking to the molds during curing.

In paper manufacturing, it is used as a lubricant to prevent the fibers from sticking to processing equipment. Moreover, magnesium stearate is a white, powdery substance that is widely used as a lubricant and flow agent in the production of pharmaceuticals, cosmetics, and food. It is added to tablets and capsules to improve their flow properties and to prevent them from sticking to the processing equipment. In cosmetics, it is added to creams and lotions to improve their texture and consistency. In food manufacturing, it is used as a flow agent to prevent ingredients from clumping together.

The metallic stearates industry is segmented based on end-use industries. Metallic stearates can be used in polymer & rubber, pharmaceuticals & cosmetics, building & construction, paints & coatings, and in other end-use industries. Pharmaceuticals & cosmetics and food segment is projected to witness highest cagr during the forecast period. In pharmaceuticals & cosmetics industry, metallic stearates such as magnesium stearate and calcium stearate are widely used as excipients to improve the physical and chemical properties of medications and cosmetic products. In the pharmaceutical industry, magnesium stearate is used as a lubricant to prevent ingredients from sticking to tablet presses and allows for easy ejection of tablets, while calcium stearate is used as a flow agent in the production of powders.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=157185802 

In cosmetics, metallic stearates are used as bulking agents, thickeners, and anti-caking agents to improve the texture, stability, and performance of cosmetic products. Zinc stearate is also used as a matting agent in cosmetic powders to create a matte finish. On the other side, in polymer & rubber industry, metallic stearates such as zinc stearate and calcium stearate, are widely used as release agents and lubricants. Zinc stearate is particularly effective as a release agent in the production of rubber and polyurethane foam, helping to prevent these materials from sticking to molds during production. Calcium stearate, on the other hand, is often used as a lubricant and release agent in the production of plastics, rubber, and paper. Metallic stearates also help to improve the processing characteristics of rubber and polymer materials, such as their flow and viscosity, and can act as stabilizers to prevent degradation during processing and storage.

The metallic stearates market is studied in five regions, namely, Asia Pacific, Europe, North America, the Middle East & Africa, and South America. Asia Pacific is the fastest-growing market of metallic stearates globally. This is attributed to many factors such as the region has a rapidly expanding industrial sector, particularly in the areas of plastics, rubber, and construction, which are the major end-use industries for metallic stearates. Additionally, the region has a large and growing population, which is driving demand for consumer goods, including cosmetics and pharmaceuticals, which are other key end-use industries for metallic stearates. Moreover, many of the major metallic stearate manufacturers have operations in the region, attracted by the region’s lower labor costs and favorable regulatory environment. Finally, the region’s increasing urbanization and infrastructure development are driving demand for coatings, adhesives, and lubricants, which are other key applications for metallic stearates.

Some of the leading companies involved in the manufacturing of metallic stearates are Baerlocher GmbH (Germany), Norac Additives (Norway), Faci Asia Pacific (Malaysia), Peter Greven GmbH & Co. KG (Germany), Valtris Specialty Chemicals (US), Sun Ace Kakoh (Japan), Dover Chemical Corporation (US), IRRH Specialty Chemicals (US), and others are covered in the specialty metallic stearates market. 

Request Customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=157185802 

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/metallic-stearates-market-157185802.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Metallic Stearates Market Application, Growth, Opportunities, Leading Companies, Share, Global Size, Key Segments Analysis, Regional Insights, and Forecast to 2028

Insomnia Market to Show Sustainable Growth During the Forecast Period | Taisho, Janssen, Imbrium, Merck, Idorsia, Eisai, Currax, Neurim, Vanda Pharma

“Insomnia Market”
According to DelveInsight’s assessment, the Insomnia Market was valued at USD 5,662.2 million in 2021 and is projected to experience substantial growth by 2032. The United States holds the largest share of the insomnia market compared to the EU4 (Germany, Italy, France, and Spain), the UK, and Japan. The market is expected to expand due to increasing awareness of insomnia, a growing diagnosed prevalence within the 7MM, and the introduction of new products.

The pipeline for Insomnia is dynamic, consisting of Vornorexant (TS-142), HETLIOZ (tasimelteon), Seltorexant (JNJ-42847922), Sunobinop (IMB-115), Piromelatine (Neu-P11), and Defined CBD (cannabidiol) some of which are expected to be launched during the forecast period [2022-2032].

DelveInsight’s “Insomnia Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Insomnia market size, share, trends, and growth opportunities in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).

The Insomnia market report covers emerging drugs, current treatment practices, market share of individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, key drivers & barriers impacting the market growth, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Insomnia Overview

Insomnia is a common sleep-wake disorder characterized by both nocturnal and diurnal symptoms. It involves a predominant complaint of dissatisfaction with sleep quality or duration. It is accompanied by difficulties initiating sleep at bedtime, frequent or prolonged awakenings, or early-morning awakening with an inability to return to sleep.

There is no single established cause of insomnia. However, research suggests that in many people, it results from certain physiological arousal at unwanted times, disrupting standard sleep patterns. Such arousal can include a heightened heart rate, a higher body temperature, and increased levels of specific hormones like cortisol. It also often occurs along with various mental disorders. American Academy of Sleep Medicine categorizes insomnia into short-term, chronic, and other.

Insomnia Market Key Facts

The market size of Insomnia in the seven major markets was approximately USD 5,662.2 million in 2021.

The market size in the 7MM will increase at a CAGR of 3.7% due to increasing awareness of the disease

Among the 7MM countries, the US accounted for the highest market size of Insomnia, with approximately USD 4,606.0 million in 2021.

Among EU4 and the UK, France accounted for the highest market share of insomnia with approximately USD 348.2 million in 2021, followed by Germany with approximately USD 130.2 million in the respective year, while Spain accounted for the lowest market with USD 80.8 million in 2021.

Japan accounted for approximately USD 289.6 million in 2021, which is expected to increase by 2032.

In 2021, the total diagnosed prevalent cases of insomnia were estimated to be approximately 85,968,021 cases in the 7MM. These cases are expected to increase by 2032 at a CAGR of 0.6% during the study period (2019–2032).

Among the 7MM, the United States accounted for nearly 67% of the total diagnosed prevalent cases of insomnia in the year 2021. These cases are expected to increase further during the study period (2019–2032).

As per DelveInsight analysis, there were approximately 31,564,128 cases of acute insomnia in the US and 26,086,057 cases of chronic insomnia in 2021.

According to estimates based on DelveInsight’s epidemiology model of insomnia, in 2021, in EU4 and the UK, there were approximately 9,836,407 cases of acute insomnia and 13,305,555 cases of chronic insomnia, which are expected to increase by 2032.

Insomnia Market

The market outlook section of the report helps to build a detailed comprehension of the historical, current and forecasted Insomnia market size by analyzing the impact of current and emerging pipeline therapies. It also thoroughly assesses the market drivers & barriers, unmet needs, and emerging technologies set to impact the market dynamics.

The report gives complete detail of the Insomnia market trend for each marketed drug and mid & late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, their Mechanism of Action (MOA), Route of Administration (ROA), molecule types, competition with other therapies, brand value, and their impact on the market.

Insomnia Epidemiology Assessment 

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted epidemiology trends by exploring numerous studies and research. The epidemiology section also provides a detailed analysis of diagnosed and prevalent patient pool, future trends, and views of key opinion leaders. 

The Report Covers the Insomnia Epidemiology, Segmented as –

Total Diagnosed Prevalent Cases of Insomnia in the 7MM [2019–2032]

Gender-specific cases of Insomnia in the 7MM [2019–2032]

Type-specific cases of Insomnia in the 7MM [2019–2032]

Age-specific cases of Insomnia in the 7MM [2019–2032]

Insomnia Drugs Uptake and Pipeline Development Activities

The drug uptake section focuses on the uptake rate of potential drugs recently launched in the Insomnia market or expected to be launched during the study period. The analysis covers the Insomnia market uptake by drugs, patient uptake by therapies, and sales of each drug. Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Insomnia pipeline development activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Learn How the Insomnia Market Will Evolve and Grow by 2032 @ https://www.delveinsight.com/sample-request/insomnia-market

Insomnia Therapeutics Analysis

The goal of therapy for insomnia is to improve the patient’s ability to fall asleep, stay asleep, wake and function well. According to various guidelines, insomnia is primarily treated using behavioral and psychological therapies such as CBT-I. Various pharmacological therapies, such as benzodiazepines or a combination of psychologic and pharmacologic therapies, are also recommended to ameliorate the condition. Several pharma and biotech giants are actively working in the Insomnia therapeutics domain to improve the treatment scenario further. 

Leading Companies in the Insomnia Therapeutics Market Include:

Currax Pharmaceuticals

Defined Research

Eisai

Idorsia Pharmaceuticals

Imbrium Therapeutics

Janssen Pharmaceutical

Merck

Neurim Pharmaceuticals

Taisho Pharmaceutical

Vanda Pharmaceuticals

And Many Others

Insomnia Emerging and Marketed Drugs Covered in the Report Include:

Vornorexant (TS-142): Taisho Pharmaceutical

Seltorexant (JNJ-42847922): Janssen Pharmaceutical

Sunobinop (IMB-115): Imbrium Therapeutics

HETLIOZ (tasimelteon): Vanda Pharmaceuticals

Defined CBD (cannabidiol): Defined Research

BELSOMRA (suvorexant): Merck

QUVIVIQ (daridorexant): Idorsia Pharmaceuticals

DAYVIGO (lemborexant): Eisai

SILENOR (doxepin): Currax Pharmaceuticals

CIRCADIN: Neurim Pharmaceuticals

SLENYTO: Neurim Pharmaceuticals

And Many More

The Report Covers the In-depth Assessment of the Emerging Drugs & Key Companies. Download the Sample Report to Learn More @ https://www.delveinsight.com/sample-request/insomnia-market

Table of Contents

1. Key Insights

2. Executive Summary 

3. Insomnia Competitive Intelligence Analysis

4. Insomnia Market Overview at a Glance

5. Insomnia Disease Background and Overview

6. Insomnia Patient Journey

7. Insomnia Epidemiology and Patient Population (In the US, EU5, and Japan)

8. Insomnia Treatment Algorithm, Current Treatment, and Medical Practices

9. Insomnia Unmet Needs

10. Key Endpoints of Insomnia Treatment

11. Insomnia Marketed Products

12. Insomnia Emerging Drugs and Latest Therapeutic Advances

13. Insomnia Seven Major Market Analysis

14. Attribute Analysis

15. Insomnia Market Outlook (In US, EU5, and Japan)

16. Insomnia Access and Reimbursement Overview

17. KOL Views on the Insomnia Market

18. Insomnia Market Drivers

19. Insomnia Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Insomnia Market to Show Sustainable Growth During the Forecast Period | Taisho, Janssen, Imbrium, Merck, Idorsia, Eisai, Currax, Neurim, Vanda Pharma

Achondroplasia Market is Expected to Show a Significant Growth During the Forecast Period | Pfizer, Sanofi, ProLynx, PhaseBio, Ascendis, BioMarin

“Achondroplasia Market”
According to DelveInsight, the dynamics of the Achondroplasia market are expected to shift in the coming years due to the introduction of new emerging drugs, government backing for clinical development, and a rising number of Achondroplasia cases across the 7MM.

Several major pharma and biotech giants are persistently working towards the development of novel treatment therapies that can address the defects caused by FGFR3 gene mutation. There are several promising drugs in the pipeline, including TransCon CNP (Ascendis Pharma), Infigratinib (BridgeBio), Recifercept (Pfizer), and RBM-007 (Ribomic Inc), among others.

DelveInsight’s “Achondroplasia Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Achondroplasia market size, share, trends, and growth opportunities in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).

The Achondroplasia market report covers emerging drugs, current treatment practices, market share of individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, key drivers & barriers impacting the market growth, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.

Achondroplasia Overview

Achondroplasia is a genetic disorder characterized by an unusually large head (macrocephaly), short upper arms (rhizomelic dwarfism), and short stature (adult height of approximately 4 feet). FGFR genetic alterations can cause more than 99% of Achondroplasia cases. In a small proportion of infants, symptoms like excessive accumulation of fluid around the brain (hydrocephalus) and low muscle tone (hypotonia) may happen as typical of achondroplasia. Acquisition of developmental motor milestones may also be delayed.

Achondroplasia results in short-limb skeletal dysplasia, occurring in approximately 1 in 20,000-30,000 live births. This genetic disorder is caused by a mutation in the fibroblast growth factor receptor 3 (FGFR3) gene, which occurs due to a spontaneous genetic mutation in approximately 80 percent of patients, and in the remaining 20 percent, it is inherited from a parent.

The current treatment landscape includes medications such as growth hormone therapy, surgery, and supportive therapy for achondroplasia. The first drug to be approved for treating achondroplasia is VOXZOGO (Vosoritide) by BioMarin Pharmaceuticals. The European Commission granted marketing authorization to VOXZOGO as a once-daily injection to treat achondroplasia in children from the age of 2 until growth plates are closed, which occurs after puberty when children reach final adult height, in August 2021. In November 2021, US FDA approved VOXZOGO, under accelerated approval pathway, and Rare Pediatric Disease Priority Review Voucher, fastening the approval timeline. Marketing authorization reviews are in process in Japan, Brazil, and Australia, with potential approvals in these countries in 2022.

Achondroplasia Market Key Facts

The diagnosed prevalence of achondroplasia has been increasing in the US due to improved understanding among healthcare professionals, advances in diagnosis, besides an increasing population.

Advances in genetic testing, such as chorionic villus sampling, new-generation sequencing, and amniocentesis, allow for the prenatal diagnosis of achondroplasia.

Management of achondroplasia is symptomatic and requires a multidisciplinary approach involving pharmacological and nonpharmacological interventions. The current treatment landscape has only one approved therapy in the US and Europe, VOXZOGO (vosoritide), while in Japan, growth hormone has also been authorized for the management of achondroplasia; however, its long-term benefits are controversial.

Other therapies like statins, anti-infectives, antihistamines, CNP analogs, etc, are also used to manage symptoms and aid surgical procedures of achondroplasia. Further, surgical therapies like adenotonsillectomy, suboccipital decompression, tracheostomy, laminectomy, and physical therapy play a vital role in managing several complications of achondroplasia.

One of the major concerns in understanding the achondroplasia market is the paucity of evidence to validate interventions used in the daily management of achondroplasia.

There is a lack of curative therapy; however, the presence of clinical and diagnostic guidelines, recommendations, and consensus statements have enabled informed treatment and management, the American Academy of Pediatric’s Health Supervision for Children with Achondroplasia, International Consensus Statement on the Diagnosis, Multidisciplinary Management, and Lifelong Care of Individuals with Achondroplasia, and Japanese Society for Pediatric Endocrinology’s Clinical Practice Guidelines for Achondroplasia are few among them. However, the detailed basis for recommendations and the existing uncertainties are yet to be explored.

Achondroplasia is associated with poor quality of life, substantial economic burdens, negative stereotypes, and social challenges.

In 2022, the US had the largest market size of achondroplasia among the 7MM, accounting for approximately USD 111.85 million, expected to increase further by 2032.

The approved drug is VOXZOGO (vosoritide), a C-type natriuretic peptide (CNP) analog, which acts as a positive regulator of the signaling pathway downstream of FGFR3 to promote endochondral bone growth. The drug is indicated to increase linear growth in children with achondroplasia having open epiphyses.

Although much has been learned about the disorder, limited pharmacological therapies are available, and surgeries have the risk of morbidity. There is an urgent need for an effective therapy that can restore skeletal growth and improve patients’ quality of life.

Ongoing research into achondroplasia has led to the discovery of potential therapies that might alleviate some of the symptoms and complications associated with the condition. Emerging therapies like Ascendis Pharma’s TransCon CNP (navepegritide) and QED Therapeutics (BridgeBio)/Novartis’ infigratinib (BBP-831/BGJ398) have the potential to quench the thirst for effective therapies. The achondroplasia market will change during the forecast period due to the expected approval of these emerging therapies, leading to the entry of new players in the treatment landscape.

TransCon CNP (navepegritide) is a prodrug of CNP administrated subcutaneously that regulates bone growth by maintaining CNP levels into growth plates. The delivery of TransCon CNP requires fewer doses and less quantity of CNP to elicit the therapeutic effects compared to the approved therapy VOXZOGO (vosoritide). Per DelveInsight’s analysts, the drug is anticipated to enter the US market by 2025.

Infigratinib (BBP-831/BGJ398) is an FGFR1-3 tyrosine kinase inhibitor that targets both the pathways, MAPK and STAT1, responsible for the clinical phenotype associated with achondroplasia. Further, its oral and painless administration spares children from the uncomfortable injection approach. The drug is anticipated to enter the US market by 2026 having a medium uptake.

Achondroplasia Market

The market outlook section of the report helps to build a detailed comprehension of the historical, current and forecasted Achondroplasia market size by analyzing the impact of current and emerging pipeline therapies. It also thoroughly assesses the market drivers & barriers, unmet needs, and emerging technologies set to impact the market dynamics.

The report gives complete detail of the Achondroplasia market trend for each marketed drug and mid & late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, their Mechanism of Action (MOA), Route of Administration (ROA), molecule types, competition with other therapies, brand value, and their impact on the market.

Achondroplasia Epidemiology Assessment

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted epidemiology trends by exploring numerous studies and research. The epidemiology section also provides a detailed analysis of diagnosed and prevalent patient pool, future trends, and views of key opinion leaders.

The Report Covers the Achondroplasia Epidemiology, Segmented as –

Total Prevalent Cases of Achondroplasia [2019–2032]

Age-Specific Cases of Achondroplasia [2019–2032]

Achondroplasia Drugs Uptake and Pipeline Development Activities

The drug uptake section focuses on the uptake rate of potential drugs recently launched in the Achondroplasia market or expected to be launched during the study period. The analysis covers the Achondroplasia market uptake by drugs, patient uptake by therapies, and sales of each drug. Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Achondroplasia pipeline development activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Learn How the Achondroplasia Market Will Evolve and Grow by 2032 @ https://www.delveinsight.com/report-store/achondroplasia-market

Achondroplasia Therapeutics Analysis

Several major pharma and biotech giants are developing therapies for Achondroplasia. Currently, BioMarin Pharmaceutical is leading the therapeutics market with its Achondroplasia drug candidates in the most advanced stage of clinical development.

Leading Companies in the Achondroplasia Therapeutics Market Include:

Ascendis Pharma

BioMarin Pharmaceutical

Pfizer

PhaseBio Pharmaceuticals

ProLynx Inc

QED Therapeutics (BridgeBio)

Ribomic

Sanofi

And Many Others

Achondroplasia Emerging and Marketed Drugs Covered in the Report Include:

BMN-111: BioMarin Pharmaceutical

CNP-ELP: PhaseBio

Infigratinib: QED Therapeutics (BridgeBio)

PLX138: ProLynx Inc

Recifercept (TA 46): Pfizer

SAR442501: Sanofi

TransCon CNP: Ascendis Pharma

And Many More

The Report Covers the In-depth Assessment of the Emerging Drugs & Key Companies. Download the Sample Report to Learn More @ https://www.delveinsight.com/sample-request/achondroplasia-market

Table of Contents

1. Key Insights

2. Executive Summary

3. Achondroplasia Competitive Intelligence Analysis

4. Achondroplasia Market Overview at a Glance

5. Achondroplasia Disease Background and Overview

6. Achondroplasia Patient Journey

7. Achondroplasia Epidemiology and Patient Population (In the US, EU5, and Japan)

8. Achondroplasia Treatment Algorithm, Current Treatment, and Medical Practices

9. Achondroplasia Unmet Needs

10. Key Endpoints of Achondroplasia Treatment

11. Achondroplasia Marketed Products

12. Achondroplasia Emerging Drugs and Latest Therapeutic Advances

13. Achondroplasia Seven Major Market Analysis

14. Attribute Analysis

15. Achondroplasia Market Outlook (In US, EU5, and Japan)

16. Achondroplasia Access and Reimbursement Overview

17. KOL Views on the Achondroplasia Market

18. Achondroplasia Market Drivers

19. Achondroplasia Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

Download a free sample report @ https://www.delveinsight.com/sample-request/achondroplasia-market

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Achondroplasia Market is Expected to Show a Significant Growth During the Forecast Period | Pfizer, Sanofi, ProLynx, PhaseBio, Ascendis, BioMarin